Filing Details

Accession Number:
0001209191-13-050241
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-01 19:05:59
Reporting Period:
2013-10-30
Filing Date:
2013-11-01
Accepted Time:
2013-11-01 19:05:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1337553 Aerie Pharmaceuticals Inc AERI Biological Products, (No Disgnostic Substances) (2836) 203109565
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277458 Brian Levy C/O Aerie Pharmaceuticals, Inc.
135 U.s. Highway 206, Suite 15
Bedminster NJ 07921
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-30 6,000 $10.00 6,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares of Common Stock were purchased in connection with the issuer's initial public offering (the "IPO") at the IPO price pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended, pursuant to a directed share program under which certain shares of Common Stock offered in the IPO were sold to the issuer's directors, officers, employees, consultants and other individuals associated with the issuer.